[1] [1] TAKAYUKI A, YUKI M, IKUO S. Cytosolic DNA-sensing imune response and viral infection［J］. Microbiology & Immunology, 2019, 63(2): 51-64.

[2] [2] COHEN P, STRICKSON S. The role of hybrid ubiquitin in the MyD88 and other innate immune signaling pathways［J］. Cell Death & Differentiation, 2017, 24(7): 1153-1159.

[3] [3] LI X, QIN J. Modilation of Toll-interleukin 1 receptor mediated signaling［J］. Journal of Molecular Medicine (Berl), 2005, 83(4): 258-266.

[4] [4] BELLO-IRIZARRY S N, WANG J, JOHNSTON C J, et al. MyD88 signaling regulates both host defense and immunopathogenesis during pneumocystis infection［J］. Journal of Immunology, 2014, 192(1): 282-292.

[5] [5] LORD K A, HOFFMAN-LIEBERMANN B, LIEBERMANN D A. Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6［J］. Oncogene, 1990, 5(7): 1095-1097.

[6] [6] THOMAS S Y, WHITEHEAD G S, TAKAKU M, et al. MyD88-dependent dendritic and epithelial cell crosstalk orchestrates immune responses allergens［J］. Mucosal Immunology, 2018, 11(3): 796-810.

[7] [7] YAMAMOTO M, SATO S, HEMMI H, et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway［J］. Science, 2003, 301(5633): 640-643.

[8] [8] NGO V N, YOUNG R M, SCHMITZ R, et al. Oncogenically active MyD88 mutations in human lymphoma［J］. Nature, 2011, 470(7332): 115-119.

[9] [9] BLOCK M S, VIEKANT R A, RAMBAU P F, et al. MyD88 and TLR4 expression in epithelial ovarian cancers［J］.Mayo Clinic Proceedings, 2018, 93(3): 307-320.

[10] [10] JIA R J, CAO L, ZHANG L, et al. Enhanced myeloid differentiation factor 88 promotes tumor metastasis via induction of epithelial-mesenchymal transition in human hepatocellular carcinoma［J］. Cell Death & Disease, 2014, 5(3): 1103-1104.

[11] [11] PARK G S, KIM J H. Myeloid differentiation primary response gene 88-leukotriene B4 receptor 2 cascade mediates lipopolysaccharide-potentiated invasiveness of breast cancer cells［J］. Oncotarget, 2015, 6(8): 5749-5759．

[12] [12] ECHIZEN K, HIROSE O, MAEDAO Y, et al. Infalmmation in gastric cancer:interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways［J］. Cancer Science, 2016, 107(4): 391-397.

[13] [13] CHEN X, GAO Q, ZHOU L, et al. MiR-146a alleviates inflammation of acute gouty arthritis rats through TLR4/MyD88 signal transduction pathway［J］. European Review for Medical Pharmacological Sciences, 2019, 23(21): 9230-9237.

[14] [14] ZHU X, BURFEIND K G, MICHAELIS K A, et al. MyD88 signalling is critical in the development of pancreatic cancer cachexia［J］. Journal of Cachexia Sarcopenia & Muscle, 2019, 10(2): 378-390.

[15] [15] SEWASTIANK T, GUERRERA M L, ADLER K, et al. Human MyD88L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cells［J］. Blood Advances, 2019, 3(21): 3360-3374.

[16] [16] KFOURY A, LECORF K, EISABEH R, et al. MyD88 in DNA repair and cancer cell resistance to genotoxic drugs［J］. Journal of the National Cancer institute, 2013, 105(13): 937-946.

[17] [17] KFOURY A, VIRARD F, RENNO T, et al. Dual function of MyD88 in inflammation and oncogenesis:implications for therapeutic intervention［J］. Current Opinion Oncology, 2014, 26(1): 86-91.

[18] [18] PUTTUR F, FRANCOZO M, SOLMAZ G, et al. Conventional dendritic cells confer protection against mouse cytomegalovirus infection via TLR9 and MyD88 signaling［J］.Cell Research, 2016, 17(4): 1113-1127.

[19] [19] LOIARRO M, RUGGIERO V, SETTE C. Targeting the Toll-like receptor/interleukin 1 receptor pathway in human diseases: rational design of MyD88 inhibitors［J］. Clinical Lymphoma Myeloma & Leukemia, 2013, 13(2): 222-226.

[20] [20] DE-STOPPELAAR S F, CLAUSHUIS T A, JANSEN M P, et al. The role of platelet MyD88 in host response during gram-negative sepsis［J］. Journal of Thrombosis & Haemostasis, 2015, 13(9): 1709-1720.

[21] [21] WU K, ZHANG H, FU Y, et al. TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells［J］. Molecular Medicine Reports, 2018, 18(3): 3411-3420.

[22] [22] WANG L, YU K, ZHANG X, et al. Dual functional roles of the MyD88 signaling in colorectal cancer development［J］. Biomedicine and Pharmacotherapy, 2018, 107(1): 177-184.

[23] [23] BALAJI B, SUZANNE L C. Mitochondria in innate immune signaling［J］. Translation Research, 2018, 202(12): 52-68.

[24] [24] MINHEE K, SINDHU S, JIGNESH G, et al. The role of TLR4 activation in photoreceptor mitochondrial oxidative［J］. Investigative Ophthalmology & Visual Science, 2011, 52(8): 5824-5835.

[25] [25] WU X, YANG D, ZHAO F, et al. Quantification of dynamic protein interactions and phosphorylation in LPS signaling pathway by SWATH-MS［J］. Molecular & Cellular Proteomics, 2019, 18(6): 1054-1069.

[26] [26] LANFRANCA M P, MOSTAFA H H, DAVIDO D. HSV-1 ICP0:an E3 ubiquitin ligase that counteracts host intrinsic and innate immunity［J］. Cells, 2014, 3(2): 438-454.

[27] [27] DELLA M E, BORGHESI A, ZHOU H, et al. Inherited human IRAK1 deficiency selectively impairs TLR signaling infibroblasts ［J］. Proceeding of the National Academy of Sciences of the United States of American, 2017, 114(4): 514-523.

[28] [28] KIM Y C, LEE S E, KIM S K, et al. Toll-like receptor mediated inflammation requires FASN-dependent MyD88 palmitoylation［J］. Nature Chemical Biology, 2019, 15(9): 907-916.

[29] [29] WANG H, LI M, HUNG C Y, et al. MyD88 shapes vaccine immunity by extrinsically regulating survival of CD4+ T cells during the contraction phase［J］. PloS Pathogens, 2016, 12(8): 1075-1085.

[30] [30] HUANG D J, LI Y, YANG Z Y, et al.Association of the TLR4-MyD88-JNK signaling pathway with inflammatory response intracranial hemorrhage rats and its effect on neuronal apoptosis［J］. European Review for Medical Pharmacological Sciences, 2019, 23(11): 4882-4889.

[31] [31] SAXENA A, RAUCH U, BERG K E, et al. The vascular repair process after injury of the carotid artery is regulated by IL-1RI and MyD88 signalling［J］. Cardiovascular Research, 2011, 91(2): 350-357.